Bank of Montreal
CTOR

Bank of Montreal’s Citius Oncology CTOR Stock Holding History

Bank of Montreal’s Portfolio CTOR Stock Details CTOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-73,881
Closed -$774K – 4297
2023
Q2 		$774K Buy
+73,881
New +$772K ﹤0.01% 2325

Other funds holding CTOR

WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Bank of Montreal's CTOR Position: Q3 2023 in Review

Bank of Montreal sold out of Citius Oncology (CTOR) in Q3 2023, closing a stake of 73,881 shares — an estimated $774K sold.

Bank of Montreal first reported a position in CTOR in Q2 2023 and held it in 1 quarter. The position peaked at $774K in Q2 2023. 23 funds tracked by Wall St. Rank hold CTOR as of Q3 2023.

  • Bank of Montreal reported no remaining Citius Oncology position as of Q3 2023 after selling out during the quarter.
  • Bank of Montreal sold 73,881 Citius Oncology shares in Q3 2023, an estimated $774K.
  • Bank of Montreal first reported a position in Citius Oncology in Q2 2023 and held it in 1 quarter.
  • Bank of Montreal's Citius Oncology position peaked at $774K in Q2 2023.
  • 23 funds tracked by Wall St. Rank held Citius Oncology as of Q3 2023.

Based on Bank of Montreal's 13F filing for Q3 2023, filed 1 Nov 2023.